Cat. No. 1377
Alternative Name: BRL 34915
Chemical Name: trans-3,4-dihydro-3-hydroxy-2,2-dim
Biological ActivityPrototypical Kir6 (KATP) channel opener. Relaxes rabbit isolated portal vein with an IC50 value of 21 nM . Potent, orally active and hypotensive in vivo.
Licensing InformationSold under license
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Escande et al (1988) The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytes. Biochem.Biophys.Res.Commun. 154 620. PMID: 2456760.
Longman et al (1988) Cromakalim, a potassium channel activator: a comparison of its cardiovascular haemodynamic profile and tissue specificity with those of pinacidil and nicorandil. J.Cardiovasc.Pharmacol. 12 535. PMID: 2468052.
Wilson et al (1988) Comparative effects of K+ channel blockade on the vasorelaxant activity of cromakalim, pinacidil and nicorandil. Eur.J.Pharmacol. 152 331. PMID: 2851450.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for Cromakalim include:
Lasker et al (2013) The sGC activator BAY 60-2770 has potent erectile activity in the rat. Am J Physiol Heart Circ Physiol 304 H1670. PMID: 23585129.
Do you know of a great paper that uses Cromakalim from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: Cromakalim, supplier, KATP, channel, openers, Potassium, KIR, Kir6, Channels, Inward, Rectifier, K+, BRL34915, Tocris Bioscience, Inward Rectifier Potassium (Kir) Channel Activator products
Find multiple products by catalog number
New Products in this Area
Potent and selective KV11.1 (hERG) channel blocker
Follow @Tocris on Twitter
Tocris is now actively tweeting. For regular updates on news, events and special offers, follow @Tocris on Twitter.